Trial Profile
Evaluation of Woulgan in Diabetic Foot Ulcer Compared With a Commercial Hydrogel
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Jun 2019
Price :
$35
*
At a glance
- Drugs Soluble beta 1,3-1,6 glucan (Primary)
- Indications Diabetic foot ulcer
- Focus Therapeutic Use
- Sponsors Biotec Pharmacon
- 28 May 2019 Status changed from recruiting to completed.
- 30 Jan 2018 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 30 Jan 2018 Planned primary completion date changed from 1 Oct 2017 to 1 Oct 2018.